JANDEN WEBER: Open Payments
NPI 1902501174 · CHANUTE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 36 payments from 11 companies in 2025. Trend: 2023 $17 · 2024 $232 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $256 |
| Amgen Inc. | 6 | $106 |
| PFIZER INC. | 5 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Novo Nordisk Inc | 2 | $36 |
| Insulet Corporation | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| SANOFI PASTEUR INC. | 1 | $17 |
Products named: FARXIGA, AIRSUPRA, OTEZLA, XIFAXAN, REXULTI, ELIQUIS, BREZTRI, Rybelsus.
Industry payments across KS — which companies pay providers there.
